Deng, F. Y. & Bae, Y. H. Bile acid transporter-mediated oral drug delivery. J. Control. Release 327, 100–116 (2020).
Beaudoin, J. J., Brouwer, K. L. R. & Malinen, M. M. Novel insights into the organic solute transporter alpha/beta, OSTα/β: from the bench to the bedside. Pharmacol. Therapeut. https://doi.org/10.1016/j.pharmthera.2020.107542 (2020).
Ballatori, N., Christian, W. V., Wheeler, S. G. & Hammond, C. L. The heteromeric organic solute transporter, OSTα-OSTβ/SLC51: a transporter for steroid-derived molecules. Mol. Aspects Med. 34, 683–692 (2013).
Gao, E. et al. Organic solute transporter alpha deficiency: a disorder with cholestasis, liver fibrosis, and congenital diarrhea. Hepatology 71, 1879–1882 (2020).
Sultan, M. et al. Organic solute transporter-beta (SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis. Hepatology 68, 590–598 (2018).
Collins, S. L., Stine, J. C., Bisanz, J. E., Okafor, C. D. & Patterson, A. D. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat. Rev. Microbiol. 21, 236–247 (2023).
Fleishman, J. S. & Kumar, S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct. Tar. https://doi.org/10.1038/s41392-024-01811-6 (2024).
Fang, F. et al. Neurosteroid transport by the organic solute transporter OSTα-OSTβ. J. Neurochem. 115, 220–233 (2010).
Boyer, J. L. & Soroka, C. J. Bile formation and secretion: an update. J. Hepatol. 75, 190–201 (2021).
Ferrebee, C. B. et al. Organic solute transporter α-β protects ileal enterocytes from bile acid-induced injury. Cell Mol. Gastroenter. 5, 499–522 (2018).
... continue reading